Abstract
Bone Marrow Transplantation (2002) 29, 91. doi:10.1038/sj.bmt.1703319
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rosen O, Massenkeil G, Hiepe F et al. Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (Ssc): no evidence for cyclophosphamide-induced cardiomyopathy Bone Marrow Transplant 2001 27: 657 658
Beranek JT . Quick disposal of dead cardiomyocytes: an ultimate proof of their apoptosis J Heart Lung Transplant 2001 20: 923 924
Slavin RE, Millan JC, Mullins GM . Pathology of high dose intermittent cyclophosphamide therapy Hum Pathol 1975 6: 693 709
Slavin RE, Woodruff JM . The pathology of bone marrow transplantation Pathol Annu 1974 9: 291 344
Buckner CD, Rudolph RH, Fefer A et al. High-dose cyclophosphamide therapy for malignant disease Cancer 1972 29: 357 365
Beranek JT . Pathogenesis of heart fibrosis in systemic sclerosis (letter) Int J Cardiol 2001 80: 261 262
Al-Naser IA . In vivo prevention of cyclophosphamide-induced CA2+ dependent damage of rat heart and liver mitochondria by cyclosporin A Comp Biochem Physiol [A] 1998 121: 209 214
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beranek, J. Apoptosis contributes to cyclophosphamide-induced cardiomyopathy. Bone Marrow Transplant 29, 91 (2002). https://doi.org/10.1038/sj.bmt.1703319
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703319